摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-羟基-5-甲氧基-2-甲基苯甲醛 | 42044-81-5

中文名称
4-羟基-5-甲氧基-2-甲基苯甲醛
中文别名
——
英文名称
4-hydroxy-5-methoxy-2-methylbenzaldehyde
英文别名
4-hydroxy-5-methoxy-2-methyl-benzaldehyde;4-Hydroxy-5-methoxy-2-methyl-benzaldehyd;4-Hydroxy-5-methoxy-2-methylbenzaldehyd;6-Methylvanillin
4-羟基-5-甲氧基-2-甲基苯甲醛化学式
CAS
42044-81-5
化学式
C9H10O3
mdl
MFCD18452091
分子量
166.177
InChiKey
MNMCHJAOXXQRID-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    174-175 °C(Solv: water (7732-18-5))
  • 沸点:
    302.3±37.0 °C(Predicted)
  • 密度:
    1.188±0.06 g/cm3(Predicted)
  • 溶解度:
    0.00 M

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2912499000

SDS

SDS:0974a7e057d506cf1a7cccfad5cfed18
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-羟基-5-甲氧基-2-甲基苯甲醛 在 palladium on activated charcoal 四氢吡咯sodium chloritesodium dihydrogenphosphate氢气硝酸 、 sodium hydride 、 potassium carbonate溶剂黄146 作用下, 以 四氢呋喃二甲基亚砜乙酸乙酯N,N-二甲基甲酰胺 为溶剂, 85.0 ℃ 、101.33 kPa 条件下, 反应 26.25h, 生成 Methyl 1-benzyl-7-hydroxy-6-methoxyindole-4-carboxylate
    参考文献:
    名称:
    Hydroxyindole derivatives as inhibitors of IL-1 generation. II. Synthesis and pharmacological activities of (E)-3-(7-hydroxy-6-methoxyindole-4-yl)-2-methylpropenoic acid derivatives
    摘要:
    A series of (E)-3-(7-hydroxy-6-methoxyindole-4-yl)-2-methylpropenoic acid derivatives was prepared and the inhibitory activities of its members on IL-1 generation were evaluated in an in vitro system using exudate cells from the rat carboxymethyl cellulose (CMC) induced air-pouch model. All the compounds in this new series were found to be inhibitors of IL-1 generation. In particular, the methoxy-substituted 2-phenyl compounds 28d-f were the most potent inhibitors of IL-1 generation (eg, 28d: IC50 = 0.8 mu M). The compounds in this series also inhibited IL-1 alpha and IL-1 beta generations in an in vitro system using human monocytes stimulated with LPS (eg, 28b: IC50 = 1.4 mu M (IL-1 alpha) and 0.9 mu M (IL-1 beta)).
    DOI:
    10.1016/0223-5234(96)89134-3
  • 作为产物:
    描述:
    参考文献:
    名称:
    Tobacco Smoke Chemistry. 2. Alkyl and Alkenyl Substituted Guaiacols Found in Cigarette Smoke Condensate.
    摘要:
    A series of alkyl and alkenyl substituted guaiacols, which comprise a group of biologically and organoleptically active compounds, have been synthesized. Mass spectra and GC retention times for these have been recorded and compared with those obtained for constituents of a weakly acidic fraction of smoke condensate derived from American blend type cigarettes. On the basis of these results, 25 guaiacols have been identified, 18 of which have not been detected in tobacco smoke condensate previously.
    DOI:
    10.3891/acta.chem.scand.43-0044
点击查看最新优质反应信息

文献信息

  • [EN] cGAS ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DU CGAS
    申请人:IMMUNE SENSOR LLC
    公开号:WO2017176812A1
    公开(公告)日:2017-10-12
    Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
    揭示了一种新型化合物的化学式(I),这些化合物是cGAS拮抗剂,涉及到这些化合物的制备方法、包含这些化合物的药物组合物,以及它们在医学治疗中的应用。
  • [EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL
    申请人:MERCK SHARP & DOHME
    公开号:WO2010129379A1
    公开(公告)日:2010-11-11
    This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
    这项发明涉及具有结构式I的化合物及其药学上可接受的盐,这些化合物是肾外髓钾(ROMK)通道(Kir1.1)的抑制剂。式I的化合物可用作利尿剂和钠利尿剂,因此可用于治疗和预防由过多盐分和水分潴留引起的疾病,包括高血压和慢性和急性心力衰竭等心血管疾病。
  • Preparation of vinylphenols from 2- and 4-hydroxybenzaldehydes
    作者:Carol J. Simpson、Matthew J. Fitzhenry、N. Patrick J. Stamford
    DOI:10.1016/j.tetlet.2005.08.011
    日期:2005.10
    A straightforward, high-yielding procedure has been developed for the manufacture of substituted vinylphenols from 2- and 4-hydroxybenzaldehydes utilising classical Knoevenagel condensation reaction conditions.
    已经开发了一种简单的高产率方法,用于利用经典的Knoevenagel缩合反应条件从2-和4-羟基苯甲醛生产取代的乙烯基苯酚。
  • Inhibitors of the renal outer medullary potassium channel
    申请人:Pasternak Alexander
    公开号:US08673920B2
    公开(公告)日:2014-03-18
    This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
    本发明涉及结构式I的化合物及其药学上可接受的盐,它们是肾外髓质钾(ROMK)通道(Kir1.1)的抑制剂。公式I的化合物可用作利尿剂和钠利尿剂,因此可用于治疗和预防由过度盐和水潴留引起的疾病,包括心血管疾病,如高血压和慢性和急性心力衰竭。
  • INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
    申请人:Merck Sharp & Dohme Corp.
    公开号:US20140142115A1
    公开(公告)日:2014-05-22
    This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
    本发明涉及具有结构式I的化合物及其药学上可接受的盐,这些化合物是肾外髓质钾通道(Kir1.1)的抑制剂。公式I的化合物可用作利尿剂和钠利尿剂,因此可用于治疗和预防由过度盐和水潴留引起的疾病,包括高血压和慢性和急性心力衰竭等心血管疾病。
查看更多